Voters in November pushed Colorado to the forefront of a psychedelic-assisted therapy movement for mental health, becoming the second state behind Oregon to approve the use of hallucinogenic mushrooms for therapeutic use.
The move comes after the Food and Drug Administration labeled psilocybin, a psychedelic compound in mushrooms, a “breakthrough therapy” for depression in an effort to help speed scientific research in the area.
In the articles below, University of Colorado Anschutz Medical Campus experts delve into the issue, looking at the long history of psychedelic research and what scientists are learning today.